2023 - Research.com Medicine in Sweden Leader Award
2023 - Research.com Molecular Biology in Sweden Leader Award
Her primary areas of study are Genetics, Cancer, Breast cancer, Internal medicine and Colorectal cancer. Genetics is a component of her Genome-wide association study, Germline mutation, Locus, Allele and DNA mismatch repair studies. Annika Lindblom interconnects Odds ratio, Genetic variation, Genetic predisposition and Genetic association in the investigation of issues within Genome-wide association study.
The various areas that she examines in her Breast cancer study include TOX3, Single-nucleotide polymorphism and Cancer research. Her research on Internal medicine often connects related areas such as Oncology. Her work deals with themes such as Carcinogenesis, Gene, Adenoma and Gastroenterology, which intersect with Colorectal cancer.
Her primary scientific interests are in Internal medicine, Breast cancer, Oncology, Genetics and Cancer. Her study focuses on the intersection of Breast cancer and fields such as Single-nucleotide polymorphism with connections in the field of Haplotype. She has researched Oncology in several fields, including Bioinformatics, Confidence interval, Disease, Endometrial cancer and Risk factor.
Her studies in Genome-wide association study, Locus, Gene, Allele and Germline mutation are all subfields of Genetics research. Her Genome-wide association study research is multidisciplinary, incorporating perspectives in Candidate gene, Genetic association and Genetic predisposition. Her research integrates issues of Mutation, Gynecology, Genetic counseling and Pathology in her study of Cancer.
Annika Lindblom mainly focuses on Internal medicine, Oncology, Colorectal cancer, Cancer and Breast cancer. Her study in Oncology is interdisciplinary in nature, drawing from both Prostate cancer, Ovarian cancer, Primary tumor, Endometrial cancer and Family history. Colorectal cancer is a subfield of Genetics that Annika Lindblom explores.
Her Cancer study integrates concerns from other disciplines, such as Lower risk and Gene. Her Breast cancer research integrates issues from Medical genetics, Germline mutation, Proportional hazards model and Cancer research. Her work in Lynch syndrome covers topics such as MSH6 which are related to areas like MLH1 and MSH2.
The scientist’s investigation covers issues in Internal medicine, Oncology, Colorectal cancer, Cancer and Genome-wide association study. Her work on Odds ratio, Cancer prevention, Aspirin and Family history as part of general Internal medicine research is frequently linked to Risk assessment, thereby connecting diverse disciplines of science. Her biological study spans a wide range of topics, including Confidence interval, Ovarian cancer, Breast cancer, Endometrial cancer and Cohort.
Her Breast cancer study combines topics from a wide range of disciplines, such as Germline mutation and Prostate cancer. Particularly relevant to Lynch syndrome is her body of work in Cancer. Her Genome-wide association study study combines topics in areas such as Medical genetics, Disease and Hazard ratio.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families
D Ford;D F Easton;M Stratton;S Narod.
American Journal of Human Genetics (1998)
Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite Instability
Asad Umar;C. Richard Boland;Jonathan P. Terdiman;Sapna Syngal.
Journal of the National Cancer Institute (2004)
Mutation in the DNA mismatch repair gene homologue hMLH 1 is associated with hereditary non-polyposis colon cancer
Bronner Ce;Baker Sm;Morrison Pt;Warren G.
Erratum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer (Nature Genetics (2009) 41 (991-995))
Xifeng Wu;Yuanqing Ye;Lambertus A. Kiemeney;Patrick Sulem.
Nature Genetics (2009)
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
Kyriaki Michailidou;Per Hall;Anna Gonzalez-Neira;Maya Ghoussaini.
Nature Genetics (2013)
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
John Burn;Anne Marie Gerdes;Finlay MacRae;Jukka Pekka Mecklin.
The Lancet (2011)
RAD51B in Familial Breast Cancer
Liisa M. Pelttari;Sofia Khan;Mikko Vuorela;Johanna I. Kiiski.
PLOS ONE (2016)
Association analysis identifies 65 new breast cancer risk loci
Kyriaki Michailidou;Kyriaki Michailidou;Sara Lindström;Sara Lindström;Joe Dennis;Jonathan Beesley.
Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer.
Simon N Stacey;Andrei Manolescu;Patrick Sulem;Thorunn Rafnar.
Nature Genetics (2007)
Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts
Hans F A Vasen;Ignacio Blanco;Katja Aktan-Collan;Jessica P Gopie.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: